STAAR Surgical: Alcon Exercises Share Repurchase Right
Ticker: STAA · Form: DEFA14A · Filed: Dec 19, 2025 · CIK: 718937
| Field | Detail |
|---|---|
| Company | Staar Surgical Co (STAA) |
| Form Type | DEFA14A |
| Filed Date | Dec 19, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-action, contractual-obligation, ophthalmic-goods
TL;DR
Alcon's making STAAR buy back shares, big move coming.
AI Summary
STAAR Surgical Company (STAAR) filed a DEFA14A on December 19, 2025, indicating that Alcon has exercised its right to require STAAR to repurchase certain shares. The filing is a definitive additional material, and no fee was required for this filing.
Why It Matters
This filing signals a significant event where a major player, Alcon, is exercising a contractual right related to STAAR's shares, potentially impacting ownership and future strategic decisions.
Risk Assessment
Risk Level: medium — The exercise of a repurchase right by a major entity like Alcon can indicate strategic shifts or financial implications for STAAR Surgical.
Key Players & Entities
- STAAR Surgical Company (company) — Registrant
- Alcon (company) — Party exercising repurchase right
- 20251219 (date) — Filing date
FAQ
What is the specific nature of the shares Alcon is requiring STAAR Surgical to repurchase?
The filing does not specify the exact nature or number of shares subject to the repurchase right, only that Alcon has exercised this right.
When did Alcon exercise its right to require STAAR Surgical to repurchase shares?
The press release mentioned in the filing was issued on December 19, 2025, indicating the exercise of the right occurred around this date.
What is the financial impact of Alcon exercising this repurchase right on STAAR Surgical?
The filing does not provide specific financial figures related to the repurchase, but it indicates a contractual obligation for STAAR Surgical.
Is this filing a preliminary or definitive proxy statement?
This filing is classified as 'Definitive Additional Materials'.
What is the SIC code for STAAR Surgical Company?
The Standard Industrial Classification (SIC) code for STAAR Surgical Company is 3851, which corresponds to Ophthalmic Goods.
Filing Stats: 1,426 words · 6 min read · ~5 pages · Grade level 14.6 · Accepted 2025-12-19 15:23:40
Filing Documents
- d22098ddefa14a.htm (DEFA14A) — 22KB
- g22098g1219225949104.jpg (GRAPHIC) — 3KB
- 0001193125-25-326690.txt ( ) — 27KB
Forward-Looking Statements
Forward-Looking Statements The information covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "anticipate," "believe," "expect," "plan," "estimate," "project," "continue," "will," "should," "may," and similar terms. All statements in this communication that are not statements of historical fact are forward-looking statements. These forward-looking statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Alcon merger agreement or could cause the consummation of the proposed transaction to be delayed or to fail to occur; (2) the failure to obtain approval of the proposed transaction from STAAR's stockholders; (3) the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected timeframes or at all; (4) risks related to disruption of management's attention from STAAR's ongoing business operations due to the proposed transaction; (5) the effect of the announcement of the proposed transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6) the ability of STAAR to meet expectations regarding the timing and completion of the transaction; (7) the outcome of any legal proceedings that may be instituted against STAAR related to the proposed transaction; (8) the possibility that STAAR's stock pr